GE HealthCare price target raised to $80 from $74 at Morgan Stanley

Morgan Stanley analyst Patrick Wood raised the firm’s price target on GE HealthCare (GEHC) to $80 from $74 and keeps an Equal Weight rating on the shares. The firm said it updated its model for Q3 earnings, which were slightly above expectations. Demand is looking solid for GE HealthCare, with solid order backlog and peer results, and the firm’s hospital CapEx survey suggests a healthy environment, the analyst tells investors in a research note. The analyst added that it equally believes mid-term margin targets are sensible and sees upside risk long-term from photon counting.